Amino acid-based formula

Oral Clinical Nutrition Global Market Report 2023: Sector to Reach Grow by Over 5% Annually Through 2033 - ResearchAndMarkets.com

Retrieved on: 
Monday, March 27, 2023

The "Oral Clinical Nutrition Market by Stage, Indication Sales Channel Outlook and by Region - Global Forecast to 2023-2033" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Oral Clinical Nutrition Market by Stage, Indication Sales Channel Outlook and by Region - Global Forecast to 2023-2033" report has been added to ResearchAndMarkets.com's offering.
  • The oral clinical nutrition market size is estimated to be USD 15,358.7 million in 2022 and is expected to witness a CAGR of 5.42% during the forecast period 2023-2033.
  • However, uncertain perceptions of therapeutic nutrition and a decline in birth rates are anticipated to hinder the market growth.
  • clinical nutrition plays a significant role in avoiding harmful effects for patients during procedures and allowing surgeons to operate in a controlled environment.

Danone Announces New Hypoallergenic Baby Formula Brand Pepticate, Now Available in the U.S.

Retrieved on: 
Monday, March 6, 2023

WHITE PLAINS, N.Y. and BROOMFIELD, Colo., March 6, 2023 /PRNewswire/ -- Danone North America, today announced alongside its Specialized Nutrition business, Nutricia, the availability of Pepticate in the U.S. to help support families with food allergies as the country continues to face a formula shortage.

Key Points: 
  • Sold in Europe for more than 30 years, Pepticate is Europe's #1 hypoallergenic extensively hydrolyzed baby formula for cow milk allergy.
  • *
    Danone's introduction of Pepticate to the U.S. builds on the company's existing efforts to alleviate the national formula shortage.
  • That's very important for families, since a good tasting formula may decrease the likelihood of formula refusal and repeated doctor visits."
  • The introduction of Pepticate to the U.S. is one of several steps Danone has taken to help American families navigate the baby formula shortage.

Danone Supports American Families by Bringing Additional Baby Formula and New Online Resource

Retrieved on: 
Thursday, August 4, 2022

WHITE PLAINS, N.Y. and BROOMFIELD, Colo., Aug. 4, 2022 /PRNewswire/ -- Danone North America, the purpose-driven food and beverage leader, today announced alongside its Specialized Nutrition business, Nutricia, it will introduce a new specialty medical baby formula, to the U.S. market this Fall. Continuing its efforts to help families navigate the baby formula shortage, Danone has also launched an online website, https://operationformulaforfamilies.com, that will serve to connect parents with helpful resources.

Key Points: 
  • Continuing its efforts to help families navigate the baby formula shortage, Danone has also launched an online website, https://operationformulaforfamilies.com, that will serve to connect parents with helpful resources.
  • Pepticate is an extensively hydrolyzed, whey-based medical formula for children with cow's milk allergies.
  • Shane Grant, CEO at Danone North America, said:"Danone teams around the world have come together, harnessing our global capabilities to support babies and families at a critical time.
  • To further help parents and families navigate the formula shortage, Danone North America developed a new online resource, https://operationformulaforfamilies.com .

Fortini™ Infant Formula Clears FDA Review; Energy- and Nutrient-dense Formula Aims to Set New Standard in U.S. to Support Growth in Infants with, or at Risk of, Failure to Thrive

Retrieved on: 
Thursday, September 23, 2021

It is the first and only 30 kcal/fl oz formula in the U.S. that is nutritionally complete, ready-to-feed and specifically calibrated for term infants with undernutrition or failure to thrive.

Key Points: 
  • It is the first and only 30 kcal/fl oz formula in the U.S. that is nutritionally complete, ready-to-feed and specifically calibrated for term infants with undernutrition or failure to thrive.
  • All formulas marketed in the United States must meet federal nutritional, growth and safety requirements, and infant formula manufacturers must notify the FDA prior to marketing a new formula.
  • Fortini has been shown in clinical trials to be well tolerated and supports weight gain and catch-up growth in failure-to-thrive infants under medical supervision.
  • Until now, there has been no such formula available in the U.S. for term infants with failure to thrive or growth failure.

Cambrooke Introduces Advanced New Hypoallergenic Amino Acid-based Formulas: EquaCare Jr.™ and Essential Care Jr.™

Retrieved on: 
Wednesday, July 8, 2020

Ajinomoto Cambrooke, Inc., a U.S.-based therapeutic nutrition company and global provider of medical nutrition products, today introduced two essentially better hypoallergenic amino acid-based formulas for children: EquaCare Jr. and Essential Care Jr .

Key Points: 
  • Ajinomoto Cambrooke, Inc., a U.S.-based therapeutic nutrition company and global provider of medical nutrition products, today introduced two essentially better hypoallergenic amino acid-based formulas for children: EquaCare Jr. and Essential Care Jr .
  • EquaCare Jr. helps alleviate this burden, providing the essential nutrients a growing child needs, but at dramatic cost savings over similar amino acid-based formulas, said Howard Lossing, CEO of Ajinomoto Cambrooke.
  • Essential Care Jr. contains natural ingredients and is unique among leading amino acid-based formulas in being the only one with absolutely no corn syrup solids.
  • Essential Care Jr. uses Ajipure pharmaceutical-grade vegan amino acids and a proprietary blend of essential amino acids with increased leucine that may help build muscle.